Clinical trial Recruiting at 1 site Interventional Ages 6 to 12

Nurse-led program to improve sleep for children with cancer

Official title: The Dreamcatchers Programme - A Nurse-led Multicomponent Interventional Protocol to Improve Sleep Quality in Paediatric Oncology Patients: A Pilot Randomized Controlled Trial

Run by Chinese University of Hong Kong · NCT07323069 · Data updated 2026-11-12

This program will test whether nurse-led sleep education plus relaxation and breathing exercises can improve sleep for Chinese-speaking children aged 6–12 who are receiving cancer treatment.

Quick facts

Study typeInterventional
Ages6 Years to 12 Years
SexAll
Enrollment68 (estimated)
SponsorChinese University of Hong Kong
Academic / other
Drugs / interventionschemotherapy
Locations1 site (Kowloon Bay)
StatusRecruiting
StartedSeptember 15, 2025
Main results expectedJanuary 2027
Study endsJuly 2027
Registry record updatedJanuary 7, 2026
Trial IDNCT07323069 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Children aged 6–12 undergoing active cancer treatment at Hong Kong Children's Hospital who can read and communicate in Chinese and have sleep disturbance (PSQI ≥5).

Probably not a fit

Children with severe cognitive impairment, non-cancer hematological disorders, or sleep problems driven primarily by untreated medical conditions may not benefit from this intervention.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, single-blind, waitlist-controlled trial with 1:1 block randomization conducted at the ambulatory chemotherapy day center of Hong Kong Children's Hospital. Children aged 6–12 who can read and communicate in Chinese and who have a PSQI score ≥5 are randomized to receive a nurse-delivered multicomponent intervention (sleep hygiene education, progressive muscle relaxation, and breathing exercises) or waitlist control. Intervention sessions are delivered in a separate educational room and include password-protected QR-code videos for home practice; outcome assessors are blinded to group assignment to reduce observer bias. The design prioritizes outpatient attendees for consistent delivery and aims to reflect a feasible home-based approach for survivorship care.

Why it matters

Potential benefit: If successful, the program could improve sleep quality and duration, reduce fatigue, and support emotional and cognitive recovery during and after cancer treatment.

How similar studies have gone: Behavioral sleep interventions and relaxation techniques have shown benefits in pediatric oncology and survivor populations, though nurse-led multicomponent protocols in outpatient chemotherapy settings are less commonly reported.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Children who can read and communicate in Chinese
* Aged 6 to 12 years old (school-aged children).
* Diagnosed with cancer and currently undergoing active treatment.
* Identified as experiencing sleep disturbances, defined by a Chinese Pittsburgh Sleep Quality Index (PSQI) global score of ≥5.

Exclusion Criteria:

* Diagnosed with hematological diseases unrelated to cancer (e.g., sickle cell anemia, thalassemia).
* Presence of severe cognitive impairment, which may hinder the ability to follow instructions or engage with intervention components.

Where it's running

  • Hong Kong Children's Hospital
    Kowloon Bay, Hong Kong
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.